98%
921
2 minutes
20
Introduction: Bariatric surgery is effective in treating severe obesity, but weight recurrence (WR) after the procedure is a growing concern. The lack of consensus on cutoff points to define WR and its association with comorbidities is still a gap in the literature.
Objective: To evaluate the prevalence of WR obtained through different cutoff points in patients who underwent bariatric surgery and its association with cardiometabolic risk markers.
Methods: A cross-sectional observational study was carried out with patients who underwent bariatric surgery more than two years ago through the public health system from 2011 to 2019. Data collection was performed in person and remotely, with an assessment of anthropometric and metabolic variables. WR was analyzed in different percentages (15%, 25%, 35%, 45%) and associated with metabolic and biochemical variables.
Results: Ninety-five individuals participated in this study; 84.2% were women aged 43 years (range 22 to 66 years). Individuals with WR ≥ 15% had significantly higher insulin and HOMA-IR values vs. WR < 15%, while those with WR ≥ 25% also had reduced ferritin levels and higher TyG index values vs. WR < 25%. For the first time, it was observed that subjects with WR ≥ 35% had higher triglyceride levels vs. WR < 35%. No significant difference in metabolic variables was observed when WR ≥ 35% was compared with WR ≥ 45%.
Conclusion: WR ≥ 15% was associated with some cardiometabolic risk markers, and these remain as WR increases.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11695-025-08010-4 | DOI Listing |
J Obes Metab Syndr
September 2025
Integrated Perioperative Geriatric Excellent Research Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Background: Morbid obesity is a well-established risk factor for cardiovascular disease. Diastolic dysfunction, particularly in non-cardiac surgeries, has been associated with increased incidence of adverse cardiovascular events. This study aimed to evaluate the prevalence of diastolic dysfunction in morbidly obese patients undergoing bariatric surgery and to identify associated clinical risk factors using transesophageal echocardiography (TEE).
View Article and Find Full Text PDFDiabetes Res Clin Pract
September 2025
Department of Intensive Care Medicine, Chi Mei Medical Center, Tainan, Taiwan; School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan. Electronic address:
Obes Surg
September 2025
Department of Nephrology, Xinqiao Hospital, Army Medical University, Chongqing, China.
Obes Surg
September 2025
Department of Medical and Surgical Sciences, Internal Medicine Unit, Columbus-Gemelli Hospital, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Obesity is a globally prevalent condition associated with elevated morbidity and mortality. Metabolic and bariatric surgery offers a definitive treatment for class III (BMI > 40) obesity, achieving substantial, enduring weight loss and improving metabolic health. Despite extensive research on the physical benefits, comparatively fewer reviews investigate the psychosocial and relational changes accompanying these procedures.
View Article and Find Full Text PDFObes Surg
September 2025
Department of Minimally Invasive Digestive Surgery, Antoine Béclère Hospital, AP-HP, 157 Rue de La Porte de Trivaux, 92141 Clamart, Clamart, France.
Background: Bariatric surgery (BS) is the most effective treatment for severe obesity, but a significant proportion of patients experience insufficient weight loss (IWL) or weight regain. Glucagon-like peptide-1 receptor agonists (arGLP-1) have emerged as a promising adjunctive therapy for managing these suboptimal outcomes. This study evaluates the efficacy and safety of arGLP-1 in patients with IWL or WR after BS.
View Article and Find Full Text PDF